Medistim ASA

BATS-CHIXE:MEDIO Stock Report

Market Cap: kr4.7b

Medistim Management

Management criteria checks 4/4

Medistim's CEO is Kari Krogstad, appointed in Sep 2009, has a tenure of 13.17 years. total yearly compensation is NOK6.40M, comprised of 44.2% salary and 55.8% bonuses, including company stock and options. directly owns 0.35% of the company’s shares, worth NOK16.40M. The average tenure of the management team and the board of directors is 12.3 years and 9.2 years respectively.

Key information

Kari Krogstad

Chief executive officer

kr6.4m

Total compensation

CEO salary percentage44.2%
CEO tenure13.2yrs
CEO ownership0.3%
Management average tenure12.3yrs
Board average tenure9.2yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Kari Krogstad's remuneration changed compared to Medistim's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2022n/an/a

kr98m

Jun 30 2022n/an/a

kr92m

Mar 31 2022n/an/a

kr93m

Dec 31 2021kr6mkr3m

kr91m

Sep 30 2021n/an/a

kr88m

Jun 30 2021n/an/a

kr84m

Mar 31 2021n/an/a

kr70m

Dec 31 2020kr6mkr3m

kr69m

Sep 30 2020n/an/a

kr71m

Jun 30 2020n/an/a

kr74m

Mar 31 2020n/an/a

kr75m

Dec 31 2019kr4mkr3m

kr70m

Sep 30 2019n/an/a

kr79m

Jun 30 2019n/an/a

kr73m

Mar 31 2019n/an/a

kr64m

Dec 31 2018kr4mkr2m

kr57m

Sep 30 2018n/an/a

kr46m

Jun 30 2018n/an/a

kr48m

Mar 31 2018n/an/a

kr45m

Dec 31 2017kr4mkr2m

kr48m

Sep 30 2017n/an/a

kr41m

Jun 30 2017n/an/a

kr39m

Mar 31 2017n/an/a

kr41m

Dec 31 2016kr3mkr2m

kr39m

Sep 30 2016n/an/a

kr45m

Jun 30 2016n/an/a

kr45m

Mar 31 2016n/an/a

kr43m

Dec 31 2015kr3mkr2m

kr40m

Compensation vs Market: Kari's total compensation ($USD642.44K) is below average for companies of similar size in the UK market ($USD1.02M).

Compensation vs Earnings: Kari's compensation has been consistent with company performance over the past year.

CEO

Kari Krogstad (58 yo)

13.2yrs

Tenure

kr6,395,468

Compensation

Ms. Kari Eian Krogstad serves as Director at Vistin Pharma ASA since June 24, a2020. She has been the Chief Executive Officer of Medistim ASA since September 1, 2009 and serves as its President. Ms. Krogst...

Leadership Team

NamePositionTenureCompensationOwnership
Kari Krogstad
CEO & President13.2yrskr6.40m0.35%
NOK 16.4m
Thomas Jakobsen
Chief Financial Officerno datakr2.00m0.14%
NOK 6.7m
Helge Borslid
Vice President of Operations & Manufacturingno datakr1.43mno data
Hæge Johanne Wetterhus
Vice President of Marketing12.3yrskr1.49m0.0036%
NOK 170.3k
Roger Morberg
Vice President of Sales12.3yrskr1.71m0.070%
NOK 3.3m
Hakon Grothe
Chief Innovation Officer3.6yrskr1.41m0.024%
NOK 1.1m
Ole Robsrud
CEO of Medistim Norge AS & MD of Medistim Norge ASno datakr1.40m0.0073%
NOK 340.6k
Mike Farbelow
President of Medistim USA Incno datakr2.86m0.011%
NOK 511.3k
Cindy Kaffai
Country Manager of Medistim Deutschland GmbHno datakr1.68mno data

12.3yrs

Average Tenure

58yo

Average Age

Experienced Management: MEDIO's management team is seasoned and experienced (12.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Torben Jorgensen
Deputy Chairman2.6yrsno datano data
Oyvin Broymer
Chairman22.8yrskr400.00kno data
Lars Ronn
Independent Director12.8yrskr225.00k0.0019%
NOK 90.1k
Siri Furst
Independent Director9.6yrskr225.00k0.011%
NOK 514.1k
Tove Raanes
Independent Director8.8yrskr225.00kno data
Anthea Arff-Pettersen
Directorless than a yearno datano data

9.2yrs

Average Tenure

64yo

Average Age

Experienced Board: MEDIO's board of directors are considered experienced (9.2 years average tenure).

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.